Ophthalmology
-
Randomized Controlled Trial Comparative Study Clinical Trial
Argon laser peripheral iridoplasty versus conventional systemic medical therapy in treatment of acute primary angle-closure glaucoma : a prospective, randomized, controlled trial.
To study whether argon laser peripheral iridoplasty (ALPI) is as effective and safe as conventional systemic medications in treatment of acute primary angle-closure glaucoma (PACG) when immediate laser peripheral iridotomy is neither possible nor safe. ⋯ Argon laser peripheral iridoplasty significantly is more effective than conventional systemic medications in reducing IOP levels in acute PACG in eyes not suitable for immediate laser peripheral iridotomy within the first 2 hours from the initiation of treatment. Argon laser peripheral iridoplasty is a safe and more effective alternative to conventional systemic medications in the management of acute PACG not amenable to immediate laser peripheral iridotomy.
-
To identify and characterize the loss of stereopsis observed in patients with lesions of the optic chiasm. ⋯ The difficulty with stereopsis in patients with lesions of the optic chiasm is most likely caused by the compression of the decussating optic nerve fibers resulting in the loss of an overlapping visual field at the fixation point. Stereo tests were demonstrated to be simple and effective adjunctive tests for suspected chiasmal compression.